13FPulse
IA

IART INTEGRA LIFESCIENCES HOLDING

2026Q2 · CUSIP 457985208 · Sector: Healthcare & Biotech

Normal

Fund flows are within the usual range

Funds that own it
206
Institutions that reported holding it to the SEC
Net increase in holders
+5
Last quarter 201 → now 206
How unusual is that
Above average
Stronger buying than 56% of US stocks
What the filings say, in one paragraph

206 funds held IART at the end of 2026Q2, up 5 from the quarter before. Fund flows are within the usual range — nothing unusual. On the business itself, revenue over the last 12 months was $1.6B(YoY +1.6%), return on equity is -0.7%. IART has had 7 buying rushes in its history, and the price moved -4.5% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2013Q3: holders=129 2013Q4: holders=142 2014Q1: holders=143 2014Q2: holders=143 2014Q3: holders=144 2014Q4: holders=159 2015Q1: holders=168 2015Q2: holders=187 2015Q3: holders=189 2015Q4: holders=184 2016Q1: holders=192 2016Q2: holders=209 2016Q3: holders=232 2016Q4: holders=220 2017Q1: holders=238 2017Q2: holders=224 2017Q3: holders=212 2017Q4: holders=219 2018Q1: holders=235 2018Q2: holders=255 2018Q3: holders=246 2018Q4: holders=246 2019Q1: holders=258 2019Q2: holders=262 2019Q3: holders=281 2019Q4: holders=279 2020Q1: holders=258 2020Q2: holders=262 2020Q3: holders=236 2020Q4: holders=250 2021Q1: holders=254 2021Q2: holders=264 2021Q3: holders=261 2021Q4: holders=276 2022Q1: holders=277 2022Q2: holders=280 2022Q3: holders=281 2022Q4: holders=282 2023Q1: holders=279 2023Q2: holders=282 2023Q3: holders=260 2023Q4: holders=285 2024Q1: holders=279 2024Q2: holders=239 2024Q3: holders=224 2024Q4: holders=223 2025Q1: holders=220 2025Q2: holders=208 2025Q3: holders=208 2025Q4: holders=208 2026Q1: holders=201 2026Q2: holders=206 -40 -20 +0 +20 +40 116208300 13Q315Q116Q318Q119Q321Q122Q324Q125Q326Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 7 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2019Q3 Top 10% +4.3% -14.6%
2018Q2 Top 20% -11.8% -14.1%
2018Q1 Top 20% -7.0% -18.1%
2017Q1 Top 10% +7.2% +1.5%
2016Q3 Top 10% +9.9% +17.9%
2016Q2 Top 20% -5.5% +4.6%
2015Q2 Top 10% +0.1% -8.5%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
119
Change in large funds
+2
Total value they hold
$1.3B
Funds buying for the first time
46
Funds that sold out entirely
41
Price change that quarter
+19.1%
Funds holding puts (bearish)
0
Funds holding calls (bullish)
0

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
EPS (TTM)
$-0.10
EPS YoY
Revenue (TTM)
$1.6B
Revenue YoY
+1.6%
Net margin
-0.4%
ROE
-0.7%
Debt ratio
70.7%
FCF (TTM)
$26M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2021-09-30: EPS 0.51 2021-12-31: EPS 0.53 2022-03-31: EPS 0.39 2022-06-30: EPS 0.54 2022-09-30: EPS 0.60 2022-12-31: EPS 0.63 2023-03-31: EPS 0.29 2023-06-30: EPS 0.05 2023-09-30: EPS 0.24 2023-12-31: EPS 0.26 2024-03-31: EPS -0.04 2024-06-30: EPS -0.16 2024-09-30: EPS -0.14 2024-12-31: EPS 0.25 2025-03-31: EPS -0.33 2025-06-30: EPS -6.31 2025-09-30: EPS -0.07 2025-12-31: EPS -0.03 2026-03-31: EPS -0.06 2026-06-30: EPS 0.06 0M 221M 443M $M -6.94 -3.12 0.69 2016201720182019202020212022202320242025202606/26 Revenue EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 28 22 49 75 20222023202420252026

P/E = close around day 47 after quarter-end ÷ TTM EPS then; this is a consistent valuation date, not the company’s actual filing date; loss quarters hidden

Quarterly free cash flow
-40M22M85M 20162017201820192020202120222023202420252026
Latest quarter $-5M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.